Advertisement

Adenoma to colonic carcinoma transformation

Pathologist
Oct. 26, 2018
Advertisement

More Related Content

Advertisement
Advertisement

Adenoma to colonic carcinoma transformation

  1. Adenoma to Colonic Carcinoma transformation Dr.Vikram Prabhakar (DCP,DNB)
  2. p53 • Guardian gene, located on short arm of chromosome 17 (17p13.1)
  3. WNT pathway
  4. EGFR-KRAS • Encode proteins that regulate cellular signal transduction of extracellular growth signals(e.g., epidermal growth factors) to the nucleus • Point mutations resulting in a constitutively active GTP- bound protein and a continuous growth stimulus. • The activation of RAS genes can promote cell survival and suppress apoptosis
  5. CpG Island
  6. CpG island • Region of the genome with high frequency of CpG sites than the rest of the genome. • Formal Definition - CpG island is a region with at least 200 bp, and a GC percentage that is greater than 50 % . • CpG is shorthand for “—C—phosphate—G— that is, cytosine and guanine separated by only one phosphate
  7. Genome ~ 3 billion characters. Find gene ?
  8. Importance of CpG Islands • CpG island acts as a proxy to identify a gene. • They often occur at the start of the gene.
  9. • microsatellites are short, sequences of 1 to 6 nucleotide base pairs which are repeated dozens to hundred times throughout the genome. – aka simple sequences or short tandem repeats • are a ubiquitous component of the genome of higher organisms. • The most common microsatellite in humans is a dinucleotide repeat of the nucleotides C and A, which occurs tens of thousands of times across the genome. • microsatellite loci with many repeats are rarely detected in the genome Microsatellites
  10. Microsatellites… • due to their repetitive nature they are liable for backward slippage during DNA replication, if miss-match repair genes are defective, so that the same short sequence is copied twice – a higher number of repeats causes a higher mutation rates single-stranded loop or insertion/deletion loops
  11. • CRC accounts for about 9 percent of all cancer deaths; ranks third in both incidence and cause of cancer death in both men and women. • Approximately 782,000 new cases are diagnosed worldwide each year, of which 70% originate in the colon and the rest in the rectum
  12. Etiology Genetic mutations • inherited – can be transmitted from parent to offspring – occurs at or before fertilization • Acquired – occurs spontaneously in the sperm, ovum, or zygote - future progeny may inherit such mutation – somatic mutation - during the growth and/or development • Common in CRC (65%)
  13. Types of CRC • Sporadic = 70% of cases – there is no family history, common above age of 50 • Inherited = 1 – 6% of cases – Hereditary NonPolyposis CRC (HNPCC, Lynch syndrome) – Multiple polyps CRC • familial adenomatous polyposis (FAP) • hamartomatous polyposis syndromes (e.g. Peutz-Jeghers, juvenile polyposis) • MUTYH-associated polyposis (MAP) • Familial CRC = 25% of cases – have a family history of CRC, but the pattern is not consistent and the risk is not as high as with the inherited syndromes. • single affected first-degree relative = 1.7 ↑ed risk • two affected first-degree relatives or if Dx before age 55 = Further ↑ risk
  14. The adenoma-carcinoma sequence • Most CRCs arise from adenomas (adenomatous polyps) which are formed when normal mechanisms regulating epithelial renewal are disrupted. • the accumulation of multiple germ-line or somatic mutations determines the behavior of a tumor • cancers result from the stepwise accumulation of multiple somatic mutations. Therefore, many CRCs remain asymptomatic for years before diagnosis.
  15. • Comprehensive sequencing has revealed that individual CRCs harbor an average of 76 gene mutations and the mutated genes in the 2 tumors overlap to only a small extent; a few genes such as APC are mutated at high frequency, whereas a much larger number of genes are mutated at relatively low frequency.
  16. MOLECULAR PATHOGENESIS /Molecular tumorigenesis/ CRC can arise in more than one molecular pathways 1. Chromosomal instability (CIN), 2. Mismatch repair pathway 3. Epigenetic gene silencing
  17. 1. The chromosomal instability (CIN/APC) pathway • encompasses 80% to 85% of all CRC and adenoma • Result in abnormal karyotypes, gross chromosomal abnormalities, such as aneuploidy, chromosome rearrangement, oncogene activation and loss of heterozygosity of tumor suppressor genes. • Results "gain of function" mutations which may result in – loss or mutation of tumor suppressor genes such as APC, TP53 – activation of oncogenes such as KRAS – apoptotic pathways • CRC caused by CIN usually have poor prognosis
  18. • In 90% of CRCs inactivation of the Wnt signaling pathway /APC or β-catenin gene/; usually by mutation of one copy of the APC gene (70%). • a tumor suppressor adenomatous polyposis coli gene mutation + (allelic deletion or an additional mutation → inactivation of the other allele) → development of dysplasia in aberrant crypt foci and early adenomas → accumulation of additional genetic mutations (KRAS, DCC, p53 and others) → tumor progression
  19. kRAS oncogene • RAS mutations are found in up to 50% of sporadic CRCs and 50% of colonic adenomas larger than 1 cm; they are rarely seen in smaller adenomas → acquired during later adenoma progression • The presence of a RAS mutation in CRC is significantly associated with the absence of response to agents targeting the epidermal growth factor receptor (EGFR) such as cetuximab and panitumumab.
  20. – Causes mutation of serine/threonine protein kinase which is involved with that acts as a downstream effector of the KRAS gene. – substitution of valinefor glutamate – Not detected inany LS/HNPCCtumors – occurs in approximately 12% of all CRC, mutually exclusive of KRAS mutation – a prognostic and predictive marker to predict resistance to anti-EGFR therapy BRAF gene mutation
  21. Roleand ExpressionPatternofEpidermal GrowthFactor Receptor inColonCancer • EGFRisexpressed innormal colon epitheliumand in80-100% of colorectal cancers (by IHC) • Up to 40%response rate to anti- EGFRinwild type tumors • BRAF,NRAS,and PIK3CA exon 20mutationsare significantly associated with a low response rate
  22. 2. mismatch repair pathway /The mutator phenotype / • accounts for 15% of CRC • Mismatch repair corrects errors made when DNA is copied. For example, a C could be inserted opposite an A, or the polymerase could slip or stutter and insert two to five extra unpaired bases. • If a mismatch or small loop is found, endonuclease (MSH2 protein recognizes, MSH6 or MSH3) cuts the strand bearing the mutation and exonuclease (MLH1 and PMS2) then digests this strand. • Finally it will be filled in by normal cellular enzymes.
  23. Microsatellite instability (MSI) • due to the presence of the mismatch repair system, in vivo microsatellite mutation rates range from 10-6 to 10-2 per generation. • Mutation of both alleles of mismatch repair (MMR) system → DNA strand (microsatellites) might be displaced, and realigns out of register creating small loop of unpaired DNA → unable to remove the loops → microsatellite increases or decrease in size due to either insertion or deletion of repeating units when compared to the normal cell’s = Microsatellite instability (MSI) • MSI is implicated in 50–60% of inherited condition HNPCC(Lynch syndrome) → germline mutations
  24. 3. Epigenetic gene silencing (Hypermethylation phenotype (CIMP+)) pathway • DNA methylation is involved in normal cellular control of gene expression – (CpG island) are usually found in the regions close to promoters • characterized by methylation of a number of genes rich in CpG islands → silencing of multiple genes or promoter region → loss of gene function or transcriptional inactivation (e.g. tumor-suppressor genes, APC) • methylation phenotype (CIMP) positive tumors
  25. 3. Epigenetic gene silencing… • encompasses 35%-40% of sporadic CRC • begin with serrated polyps, especially sessile serrated adenomas (SSAs) bearing an activating mutation in the BRAF gene. • Epigenetic changes are potentially reversible by drugs. • CIMP+ CRCs – microsatellite stable (MSS) cancer (60% of CIMP+ ) or – MSI-H (40% of CIMP+) • Methylation occur in hMLH1 – methylation may occur in tumor suppressor genes
  26. • If MMR system is silenced→ MSI • CRCs with high frequency of methylation of some CpG islands are referred to as CpG island
  27. Molecular Pathologic classification of colorectal cancer
  28. FAP • FAP is the most common polyposis syndrome. • the risk of CRC by the age of 40 years is almost 100%. • It is autosomal dominant and is caused by de novo germline mutations.
  29. • The presence of FAP can be diagnosed by direct sequencing of the germ-line mutations in APC gene on chromosome 5q21. • Somatic APC mutations are also present in most sporadic colorectal adenomas and cancers.
  30. HNPCC (Lynch syndrome) • The presence of HNPCC is defined as the presence of germ-line mutation found in one of the four MMR genes, namely MLH1, MSH2, MSH6 and PMS2. • HNPCC is the most common hereditary colon cancer syndrome.
  31. • It is autosomal dominant. • 2-hit hypothesis = germline mutation in 1 copy of 1 MMR gene represents the “first hit,” and somatic inactivation of the wild type allele the “second hit.” • The BRAF gene is almost never mutated in Lynch syndrome–associated CRCs; however, KRAS and p53 mutations can be present.
  32. Kindly Leave a message if you like the presentation and follow for further updates.
Advertisement